stocks logo

PACB Financial Analysis

Pacific Biosciences of California Inc
$
1.190
-0.040(-3.250%)

PACB Financial Analysis

FY2024Q3FY2024Q2FY2024Q1FY2023Q4FY2023Q3FY2023Q2FY2023Q1FY2022Q4FY2022Q3FY2022Q2FY2022Q1FY2021Q4FY2021Q3FY2021Q2FY2021Q1FY2020Q4FY2020Q3FY2020Q2FY2020Q1
Net Cash Flow from Operating Activities
-45.46M
-30.25%
-54.26M
30.00%
-75.68M
-20.07%
-57.56M
-4.96%
-65.18M
3.37%
-41.74M
-31.08%
-94.69M
19.82%
-60.57M
91.01%
-63.05M
55.09%
-60.56M
285.46%
-79.03M
242.06%
-31.71M
122.31%
-40.66M
128.30%
-15.71M
-33.95%
-23.10M
-130.66%
-14.26M
-21.55%
-17.81M
3.17%
-23.79M
35.48%
75.36M
Funds from Operations
-28.20M
-46.38%
-47.93M
3.65%
-50.33M
-2.38%
-49.82M
-4.59%
-52.59M
6.56%
-46.25M
-12.78%
-51.56M
-5.65%
-52.22M
21.80%
-49.35M
8.11%
-53.02M
147.38%
-54.65M
145.78%
-42.87M
-151.91%
-45.64M
178.93%
-21.43M
21.27%
-22.24M
-15.44%
82.59M
-822.73%
-16.36M
-26.24%
-17.67M
-2.07%
-26.29M
Change in Working Capital
-17.27M
37.10%
-6.33M
-240.43%
-25.35M
-41.23%
-7.74M
-7.29%
-12.60M
-8.10%
4.51M
-159.78%
-43.13M
76.91%
-8.35M
-174.79%
-13.71M
-374.76%
-7.54M
-231.75%
-24.38M
2705.41%
11.16M
-111.53%
4.99M
-445.43%
5.72M
-193.57%
-869.00K
-100.85%
-96.86M
1334.49%
-1.44M
-129.31%
-6.12M
-1353.07%
101.66M
Net Cash Flow from Investing Activities
23.07M
-90.48%
76.84M
-177.94%
-34.14M
-52.95%
-66.58M
-182.80%
242.32M
349.51%
-98.59M
63.55%
-72.55M
-272.53%
80.40M
22.28%
53.91M
-118.48%
-60.28M
-86.92%
42.05M
414.72%
65.75M
-166.76%
-291.65M
358.27%
-460.81M
16017.80%
8.17M
-115.04%
-98.50M
2790.11%
-63.64M
-423.72%
-2.86M
-136.60%
-54.33M
Capital Expenditures - Net
-787.00K
-194.82%
1.48M
-34.79%
3.88M
4.25%
2.02M
-60.18%
830.00K
-80.19%
2.27M
-43.57%
3.72M
2.28%
5.08M
78.85%
4.19M
274.35%
4.02M
156.15%
3.64M
807.23%
2.84M
4141.79%
1.12M
108.77%
1.57M
391.85%
401.00K
242.74%
67.00K
-52.48%
536.00K
-35.34%
319.00K
-47.96%
117.00K
Acquisition & Disposal of Business Sold/(Acquired)
0.00
-100.00%
0.00
0.00
0.00
-102.00K
0.00
0.00
0.00
0.00
-100.00%
0.00
0.00
0.00
-319.79M
0.00
0.00
0.00
0.00
0.00
0.00
Net Cash Flow from Financing Activities
812.00K
-203.97%
-152.00K
-96.78%
6.55M
-96.66%
-81.60M
-10063.61%
-781.00K
-124.93%
-4.72M
-1136.26%
195.99M
3658.18%
819.00K
-38.14%
3.13M
-98.95%
455.00K
-84.20%
5.22M
-99.40%
1.32M
-98.95%
299.66M
179.70%
2.88M
358.60%
865.72M
4656.97%
125.88M
594.26%
107.14M
32663.00%
628.00K
-55.14%
18.20M
Stock - Total - Issuance/(Retirement) - Net
812.00K
-82.20%
0.00
-100.00%
6.89M
-96.49%
936.00K
-24.94%
4.56M
28.76%
2.59M
204.95%
196.44M
3412.79%
1.25M
-25.95%
3.54M
-98.82%
848.00K
-71.43%
5.59M
-74.97%
1.68M
-98.66%
299.66M
179.70%
2.97M
372.61%
22.34M
11127.64%
125.88M
95989.31%
107.14M
32663.00%
628.00K
-55.14%
199.00K
Debt - LT & ST - Issuance/(Retirement)
0.00
-100.00%
-152.00K
-67.31%
-338.00K
-24.22%
-445.00K
3.97%
-486.00K
18.54%
-465.00K
18.32%
-446.00K
18.30%
-428.00K
18.56%
-410.00K
-393.00K
346.59%
-377.00K
-100.04%
-361.00K
0.00
-88.00K
895.62M
-5697.65%
0.00
0.00
0.00
-16.00M
Net Change in Cash
-21.59M
-112.24%
22.42M
-115.46%
-103.27M
-459.25%
-205.74M
-1096.02%
176.36M
-3033.48%
-145.05M
20.48%
28.75M
-190.50%
20.66M
-41.60%
-6.01M
-81.58%
-120.39M
-74.58%
-31.76M
-103.73%
35.37M
169.60%
-32.65M
-227.10%
-473.64M
1720.29%
850.79M
2068.44%
13.12M
-479.49%
25.69M
842.26%
-26.02M
211.73%
39.24M
Free Cash Flow
-45.46M
-31.13%
-55.74M
26.66%
-79.56M
-19.16%
-59.58M
-9.24%
-66.01M
-1.83%
-44.01M
-31.86%
-98.41M
19.05%
-65.65M
90.01%
-67.24M
60.96%
-64.58M
273.72%
-82.67M
251.70%
-34.55M
141.10%
-41.78M
127.73%
-17.28M
-28.32%
-23.51M
-131.24%
-14.33M
-21.78%
-18.34M
1.41%
-24.11M
32.67%
75.25M

PACB FAQs

What is PACB's PE Ratio in 2025/4/4?

PACB's PE ratio in April 4, 2025 is -1.09. This indicates the price investors are willing to pay for $1 of earnings.

What is PACB's PS Ratio in 2025/4/4?

What is PACB's Dividend Yield in 2024/Q4?

What is PACB's Gross Margin in 2024/Q4?

Free Financial AI Agent for Investment

Ask any investment related question and get answer instantly

Is PACB earnings result positive or negative?How should I trade on PACB earnings?